Victory Capital Management Inc Kal Vista Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$9.83 - $13.99 $942,067 - $1.34 Million	-95,836 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$6.75 - $12.89 $1.15 Million - $2.2 Million	-170,302 Reduced 63.99%	95,836 $1.16 Million
Q1 2020 May 04, 2020	SELL	$5.8 - $18.56 $51,927 - $166,167	-8,953 Reduced 3.25%	266,138 $2.04 Million
Q4 2019 Feb 06, 2020	BUY	$10.31 - $17.81 $3,721 - $6,429	361 Added 0.13%	275,091 $4.9 Million
Q4 2019 Feb 04, 2020	BUY	$10.31 - $17.81 $2.81 Million - $4.86 Million	272,991 Added 15698.16%	274,730 $4.2 Million
Q3 2019 Nov 12, 2019	BUY	$11.6 - $21.67 $20,172 - $37,684	1,739 New	1,739 $20,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $248M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.